Clinical trial
Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
NCT00018902 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00018902 |
|---|---|
| Title | Treatment of SSRI-Resistant Depression In Adolescents (TORDIA) |
| Official title | Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) |
| Acronym | TORDIA |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Behavioral, Drug |
| Interventions | Fluoxetine, Venlafaxine, Cognitive Behavioral Therapy (CBT), Citalopram |
| Enrollment | 334 |
| Start date | Jan 1, 2001 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jul 12, 2001 |
| Last update posted | Mar 12, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: